Similarly, decreased expression of cyclin B1 and increased expression of p21 during G2/M arrest after reversine treatment were also reported in prostate cancer (Hsieh et al., 2007) and renal cancer (Cheng et al., 2018). This evidence concerns the gene CCNB1 and Familial prostate cancer.